Anika Therapeutics, Inc. Cash and Cash Equivalents
Anika Therapeutics, Inc. (ANIK) had Cash and Cash Equivalents of $38.41 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-07-29
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $38.41M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $41.02M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $57.48M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $57.99M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $38.41M 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $41.02M 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $57.48M 10-Q · filed 2026-07-29 | |
| 2025-09-30 | $57.99M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $53.17M 10-Q · filed 2025-07-30 | |
| 2025-03-31 | $53.37M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $55.63M 10-K · filed 2026-03-03 | |
| 2024-09-30 | $62.37M 10-Q · filed 2024-11-04 | |
| 2024-06-30 | $62.82M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $68.63M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $68.74M 10-K · filed 2025-03-17 | $72.87M 10-K · filed 2024-03-15 |
| 2023-09-30 | $70.65M 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $65.07M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $79.74M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $86.33M 10-K · filed 2024-03-15 | |
| 2022-09-30 | $87.78M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $91.39M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $90.33M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $94.39M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $90.98M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $97.18M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $94.60M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $95.82M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $104.22M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $116.75M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $65.83M 10-Q · filed 2020-05-22 | |
| 2019-12-31 | $157.46M 10-K/A · filed 2021-04-26 | |
| 2019-09-30 | $103.38M 10-Q · filed 2019-10-28 | |
| 2019-06-30 | $69.41M 10-Q · filed 2019-07-26 | |
| 2019-03-31 | $95.51M 10-Q · filed 2020-05-22 | |
| 2018-12-31 | $89.04M 10-Q · filed 2020-05-22 | |
| 2018-09-30 | $81.83M 10-Q · filed 2019-10-28 | |
| 2018-06-30 | $126.05M 10-Q · filed 2019-07-26 | |
| 2018-03-31 | $141.80M 10-Q · filed 2019-05-06 | |
| 2017-12-31 | $133.26M 10-K · filed 2020-03-06 | |
| 2017-09-30 | $126.96M 10-Q · filed 2018-10-26 | |
| 2017-06-30 | $117.87M 10-Q · filed 2018-07-31 | |
| 2017-03-31 | $119.37M 10-Q · filed 2018-05-10 | |
| 2016-12-31 | $104.26M 10-K · filed 2020-03-06 | |
| 2016-09-30 | $98.05M 10-Q · filed 2017-10-27 | |
| 2016-06-30 | $89.13M 10-Q · filed 2017-07-28 | |
| 2016-03-31 | $92.84M 10-Q · filed 2017-05-04 | |
| 2015-12-31 | $110.71M 10-K · filed 2019-02-27 | |
| 2015-09-30 | $108.47M 10-Q · filed 2016-11-01 | $108.47M 10-Q · filed 2015-11-03 |
| 2015-06-30 | $103.92M 10-Q · filed 2016-08-01 | $103.92M 10-Q · filed 2015-08-04 |
| 2015-03-31 | $99.80M 10-Q · filed 2016-05-03 | $99.80M 10-Q · filed 2015-05-04 |
| 2014-12-31 | $100.16M 10-K · filed 2018-02-27 | $100.16M 10-K · filed 2015-03-13 |
| 2014-09-30 | $71.77M 10-Q · filed 2015-11-03 | |
| 2014-06-30 | $84.88M 10-Q · filed 2015-08-04 | |
| 2014-03-31 | $82.16M 10-Q · filed 2015-05-04 | |
| 2013-12-31 | $63.33M 10-K · filed 2017-02-24 | $63.33M 10-K · filed 2014-03-13 |
| 2013-09-30 | $64.06M 10-Q · filed 2014-11-06 | |
| 2013-06-30 | $54.14M 10-Q · filed 2014-08-04 | |
| 2013-03-31 | $50.97M 10-Q · filed 2014-05-05 | |
| 2012-12-31 | $44.07M 10-K · filed 2016-03-10 | $44.07M 10-K · filed 2013-03-14 |
| 2012-09-30 | $39.86M 10-Q · filed 2013-11-05 | |
| 2012-06-30 | $37.91M 10-Q · filed 2013-08-06 | |
| 2012-03-31 | $34.00M 10-Q · filed 2013-05-06 | |
| 2011-12-31 | $35.78M 10-K · filed 2015-03-13 | |
| 2011-09-30 | $29.05M 10-Q · filed 2012-11-08 | |
| 2011-06-30 | $26.83M 10-Q · filed 2012-08-07 | |
| 2011-03-31 | $29.08M 10-Q · filed 2012-05-07 | |
| 2010-12-31 | $28.20M 10-K · filed 2014-03-13 | |
| 2010-09-30 | $25.77M 10-Q · filed 2011-11-04 | |
| 2010-06-30 | $23.65M 10-Q/A · filed 2011-08-10 | |
| 2009-12-31 | $24.43M 10-K · filed 2013-03-14 | |
| 2008-12-31 | $43.19M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |